Clinical Trials Directory

Trials / Completed

CompletedNCT01097902

Study of Experimental Models of Pain and Inflammation.

Experimental Inflammatory and Micro-incisional Pain Model Analysis by Gene Expression and Interstitial Fluid Proteomics of Skin Tissue

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Martin Angst · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pain. We also hope to determine the measurable effects of a known non-steroidal anti-inflammatory drug (NSAID) on biomarkers of pain and inflammation.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen800 mg oral one time only
DRUGPlacebo tabletPlacebo tablet oral one time only

Timeline

Start date
2010-02-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2010-04-02
Last updated
2013-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01097902. Inclusion in this directory is not an endorsement.